Recent Ortho News & Developments: OSET 2021 Know Before You Go

As a tumultuous year comes to a finish, the orthopedic industry prepares to gather one last time and close out the year. The Orthopedic Summit once again comes to the Bellagio in Las Vegas, Nevada to bring together the top names in the industry. SmartTRAK will be attending OSET 2021 from December the 11th through the 14th. We've put together an overview of recent Orthopedic news highlights to get you up to speed before the meeting. If you'd like to meet with us in person, please reach out.

The following is just a small sampling of recent Orthopedics related news and updates from around the world compiled, reviewed and posted in real time every day by the expert analysts at SmartTRAK.

Markets:

• Needham Ortho Surgeon Expert Call Highlights
  During a call co-hosted by Needham, Hip and Knee surgeon Dr. Richard Berkowitz of Tamrac, FL, noted COVID accelerated the shift of recon procedures to the outpt setting w/ ~10-20% of his procedures outpt to increase to ~40-50% over the next few yrs. Needham Ortho Expert Call
  
  
• Knee Market Leaders See Share Gains in Q321
  According to SmartTRAK Financial Dashboard, US knee replacement implant market leader Zimmer Biomet* saw improved market share sequentially in Q321 compared to Q221. Stryker* also experienced an increase in share compared to Q221.
  
  
• OTA 2021 Updates
  

  DePuy Synthes* showcased their long awaited 3.5/4.5 VA-LCP Periprosthetic Femur Plate*. According to SmartTRAK discussions, the periprosthetic plate spans the femur and is currently in limited launch w/ ~50 sets in the field and full set rollout to commence next year.

Revenues:

• Anika* Q321 Earnings Report
  

  Anika reported revenue from JNJ/DePuy Synthes as a percentage of total revenue was 51% and 48% for Q321 and Q320, respectively, and 46% and 52% for the nine months ended Sept 30, 2021 and 2020, respectively. ANIKA Q321 Earnings Form 10-Q

• Stryker* Q321 Earnings Release
  

  For Q321, SYK reported US Orthopaedics business was up +13.6% vs Q320 and up +22.2% vs Q319. SYK Q321 Earnings Release

• Vericel* MACI Growth
  Vericel updated its FY21 Financial Guidance to reflect the impact of COVID-19 and recovery of MACI backlog expected to be pushed to 2022. MACI revenue growth now expected to be in the low 20% range. VCEL Q321 Earnings Presentation

New Products:

• CrossRoads Extremity* First Ray System
  

  CrossRoads Extremity Systems announced the full market launch of the First Ray System, which focuses on the DynaBunion, miniBunion, and MTP. The system will also include instrument updates to the DynaBunion system. LinkedIn

• Stryker* Prophecy Infinity Resect-Through Guides
  Stryker announced the launch of Prophecy* Infinity Resect-Through Guides for use in total ankle replacement surgeries. The instruments reduce the number of steps for TAR compared to the standard Prophecy pin-through technique.

• Exactech* Equinoxe Ergo
  Exactech announced the full launch of Equinoxe Ergo instruments supporting Equinoxe shoulders and compatible w/ ExactechGPS. The instruments represent a 50% reduction in instrument trays which may decrease cost per case for hospital and ASC-based procedures.

Deals/Financing:

• Flexion* Acquisition
  

  Pacira completed the acquisition of Flexion Therapeutics. Pacira CEO, David Stack said, “ZILRETTA is a highly complementary commercial asset that allows us to provide physicians with another tool in their pain management armamentarium to tackle OA earlier in the patient journey”.

• Globus* and Nuvasive*
  GMED has had preliminary discussions to acquire NUVA, w/ an indicative cash-and-stock offer for NuVasive made in recent weeks.
  
  
• Zimmer Biomet* Tender Offers
  Zimmer Biomet announced the commencement of tender offers to purchase for cash its 3.7% Senior Notes due 2023 and up to $1.5B aggregate price of Senior Notes due through 2039 in an effort to reduce the principal amount of its outstanding debt securities.

Clinical/Regulatory:

• Nailing vs Plating of Ankle Fxs in Elderly Pts
  A study began in Nov 2021 to compare outcomes between ankle arthrodesis w/ a calcaneal nail vs ORIF w/ plating in the fixation of fragility fxs around the ankle in elderly pts. The study is slated for completion in Dec 2026 & will include 88 participants. clinicaltrials.gov
  
  
• Arthroscopic Management of Giant Cell Tumor of the Calcaneus
  

  Arthroscopic procedure was performed for both diagnostic and curative procedures addressing a giant cell tumor of the calcaneal bone where all lesions were removed arthroscopically w/ direct lateral portals & the suspected reactive zones debrided using high-speed burr. F&A Spec

• Pacira
  Pacira’s 160-pt Phase III study plans to compare the effect of single-dose bupivacaine liposome inj via adductor canal block in pts undergoing primary unilateral total knee arthroplasty. Est study completion 08/22. clinicalrials.gov

Patents:

• Arthrex* Arthroscopic Anterior Glenoid Guide
  

  Arthrex’s US Patent Application “ARTHROSCOPIC ANTERIOR GLENOID GUIDE” was published describing an anterior glenoid guide which is a cuboid block configured to be introduced via the rotator interval to lie on the anterior glenoid. 20210369469

• Paragon 28* Intramedullary Nail Fixation Guides
  Paragon 28 was granted US Patent “Intramedullary nail fixation guides, devices, and methods of use” describing an IMN device for use in the surgical fixation of such things like a proximal tarsal-metatarsal joint. 11,179,166

• Smith+Nephew* Computer-Assisted Navigation System
  

  SNN was issued US Patent “Method for registering articulated anatomical structures” regarding a computer-assisted navigation system w/ hip surgery applications and several embodiments, including an augmented reality glasses display. 11,172,995

*These links can only be viewed by SmartTRAK subscribers. For more information on SmartTRAK, including how to receive a demo and subscribe, please click here.

Are you going to OSET? If you would like to meet with us while in Las Vegas and find out what SmartTRAK can do for you, just click the button below.